NCT03436472View on ClinicalTrials.gov

Dexmedetomidine and 5-year Outcome in Elderly Patients After Surgery

NACompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

January 8, 2019

Study Completion Date

April 1, 2019

Conditions
AgedOperativeDeliriumDexmedetomidineMortalityLong-term Survivors
Interventions
DRUG

dexmedetomidine

low-dose dexmedetomidine infusion

DRUG

placebo

normal saline infusion

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
collaborator

Peking University Third Hospital

OTHER

lead

Peking University First Hospital

OTHER

NCT03436472 - Dexmedetomidine and 5-year Outcome in Elderly Patients After Surgery | Biotech Hunter | Biotech Hunter